Our Technology

Over 100,000 Americans are currently awaiting organ transplant. Only 30 to 40% of them will receive an organ this year; 15 people die each day awaiting a transplant. Ischemia-reperfusion injury is responsible for the rejection and discarding of marginal organs, early dysfunction and failure of implanted organs, and limitations in organ transport time and geographic radius. Diatomic’s proprietary technology dramatically reduces this mode of tissue injury, thereby expanding the organ donor pool by reducing primary graft dysfunction, enabling the use of previously marginal organs, and extending the time organs can be out of the body. This technology integrates seamlessly into the existing workflow for organ recovery while redefining the standard of care and growing the number of patients who can be saved each year.